Semaglutide (Ozempic, Wegovy) – A Powerful Treatment for Diabetes and Obesity

Semaglutide, marketed as Ozempic for diabetes and Wegovy for weight loss, is a GLP-1 receptor agonist known for its potent glucose-lowering and appetite-suppressing effects.

How Semaglutide Works

Semaglutide functions by:

• Stimulating Insulin Secretion – Helps lower high blood sugar levels.
• Reducing Glucagon Release – Prevents the liver from producing excess glucose.
• Controlling Appetite – Acts on the brain to reduce hunger signals.

Primary Benefits

• Superior A1C Reduction – More effective than some older GLP-1 therapies.
• Promotes Substantial Weight Loss – Reduces food cravings and portion sizes.
• Cardiovascular Protection – Shown to reduce heart attack and stroke risks.

Potential Drawbacks

Side effects include nausea, vomiting, and digestive discomfort. Rare cases of pancreatitis and thyroid tumors have been noted.

Semaglutide is a breakthrough drug in both diabetes care and obesity treatment, making it a widely researched and prescribed GLP-1 agonist.